Antonella Insalaco

Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis

Jurgen Sota, Antonella Insalaco, Rolando Cimaz et al. · Frontiers in Pharmacology · 2019 · 616 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Clinical Features, Treatment, and Outcome of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A Multinational, Multicenter Study of 362 Patients

Francesca Minoia, Sergio Davì, AnnaCarin Horne et al. · Arthritis & Rheumatology · 2014 · 430 citations · Full text

Medicine, Hematology, Pathology +15

Mutations of <i>CD40</i> gene cause an autosomal recessive form of immunodeficiency with hyper IgM

Simona Ferrari, Silvia Giliani, Antonella Insalaco et al. · Proceedings of the National Academy of Sciences · 2001 · 377 citations · Full text

Life Sciences, Genetics, Immunology +16

The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever/EUROTRAPS international registry

Helen J. Lachmann, Riccardo Papa, Kerstin Gerhold et al. · Annals of the Rheumatic Diseases · 2013 · 336 citations · Full text

Life Sciences, Clinical Sciences, Immunology +14

Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent Pericarditis

Allan L. Klein, Massimo Imazio, Paul Cremer et al. · New England Journal of Medicine · 2020 · 334 citations · Full text

Medicine, Cardiology, Pharmacotherapy +13